14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
AXNX vs MDT: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 20, 2026, Medtronic plc (MDT) is the stronger overall head-to-head candidate over AXNX (AXNX) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). AXNX carries a Unified Composite Score of 52.1/100 (HOLD) at $0.83 (N/M Forward P/E, N/A operating margin), whereas MDT carries 44.7/100 (HOLD) at $99.94 (16.5x Forward P/E, 20.1% operating margin).
Composite vs. Pillar Nuance: While AXNX currently prints a higher short-term Unified Composite Score (52.1/100 HOLD vs. MDT 44.7/100 HOLD), MDT captures the overall institutional head-to-head verdict (9–1 matrix metrics and 6–0 across the 6 pillars) due to superior fundamental profitability (20.1% vs. N/A operating margin) and revenue trajectory (+13.7% vs. N/A YoY).
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on AXNX vs MDT. Trailing 12-month operating profitability (AXNX N/A vs MDT 20.1%) and valuation multiples (AXNX N/M vs MDT 16.5x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
MDT Moat ProfileConcentrated Oligopoly Moat
Medical Devices Operator
Competes within the Medical Devices value chain with $128.7B market capitalization and 20.1% operating margin.
OpEx & R&D Reinvestment45.2% of Rev ($17.0B)
90D Engineering Disclosures0 Published · Surgical Robotics
Investor FAQ AXNX vs MDT Key Questions & Quantitative Answers
As of Nov 20, 2026, Medtronic plc (MDT) is the stronger overall head-to-head candidate over AXNX (AXNX) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). AXNX carries a Unified Composite Score of 52.1/100 (HOLD) at $0.83 (N/M Forward P/E, N/A operating margin), whereas MDT carries 44.7/100 (HOLD) at $99.94 (16.5x Forward P/E, 20.1% operating margin). Composite vs. Pillar Nuance: While AXNX currently prints a higher short-term Unified Composite Score (52.1/100 HOLD vs. MDT 44.7/100 HOLD), MDT captures the overall institutional head-to-head verdict (9–1 matrix metrics and 6–0 across the 6 pillars) due to superior fundamental profitability (20.1% vs. N/A operating margin) and revenue trajectory (+13.7% vs. N/A YoY).
MDT leads the Growth & Scale pillar: AXNX posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with MDT at +13.7% YoY revenue growth and +40.7% YoY earnings growth on $37.5B TTM revenue (65.3% gross margin, 20.1% operating margin). On trailing 12-month operating scale, AXNX generates N/A in USD-normalized revenue versus $37.5B for MDT. In operating R&D and SG&A reinvestment, AXNX deploys N/A (0 90-day corporate R&D disclosures) versus 45.2% of Rev ($17.0B) (0 disclosures) for MDT.
MDT screens cheaper on headline valuation multiples. AXNX trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas MDT trades at 16.5x Forward P/E, 24.7x Trailing P/E, 1.81x PEG, and 4.1x EV/Revenue (16.3% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against AXNX (N/A ROE) versus MDT (10.7% ROE) capital efficiency.
In options market volatility and institutional positioning, AXNX carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (N/A realized risk). By comparison, MDT carries 34.6% implied volatility (15th %ile, Compressed (<25th %ile)), a 0.40x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (0.13β · 30% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.